Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panagen for Leukostimulation in Breast Cancer
NCT02115984Phase 2Completed
- Sponsor
- HLB PANAGENE Co., Ltd.
- Start
- May 2010
- Primary completion
- May 2012
01
Overview
A Phase 2 trial of Panagen in breast cancer, sponsored by HLB PANAGENE Co., Ltd.. Started May 2010; status: completed.
02
Drugs
Panagen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02115984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115984.